This study evaluates the impact of aminoglycosides in hypotensive septic oncologic patients. In the oncologic patient population, sepsis is a major health concern due to high mortality rates and healthcare costs. Prior research shows aminoglycosides antibiotics are frequently used to treat sepsis, but their clinical impact in hypotensive oncology patients upon the progression of sepsis is not known.
PRIMARY OBJECTIVE: I. To assess the impact of beta-lactam (BL) + aminoglycoside (AG) combination therapy in hypotensive septic oncology patients. OUTLINE: Patients' medical charts are reviewed retrospectively.
Study Type
OBSERVATIONAL
Enrollment
319
Medical record reviewed
M D Anderson Cancer Center
Houston, Texas, United States
RECRUITINGTime to resolution of hypotension
Defined as a mean arterial pressure \> 65 mmHg not requiring vasopressors and sustained for \>= 24 hours.
Time frame: Within 7 days from hypotension onset
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.